Table 1 Preoperative baseline characteristics of patients undergoing solitary SAVR with CE-Perimount bioprosthesis
Patients, n | 1604 |
Male, n (%) | 984 (61.3%) |
Age | |
 Median (IQR) | 73 (69–78) |
 Mean, years (Range) | 72.7 (20–91) |
Etiology, n (%) | |
 Aortic Stenosis | 1204 (75.1%) |
 Aortic Insufficience | 248 (15.5%) |
 Stenosis and Insufficience | 7 (0.4%) |
 Endocarditis | 30 (1.9%) |
 Others incl. Missing | 115 (7.2%) |
Valve size, n = 1601 (%) | |
 19 mm | 103 (6.4%) |
 21 mm | 346 (21.6%) |
 23 mm | 564 (35.2%) |
 25 mm | 412 (25.7%) |
 27 mm | 156 (9.7%) |
 29 mm | 20 (1.3%) |
EOAI ≥0,85 (%), n = 1483 | 1295 (87.3%) |
Ejection Fraction, n = 1469 | |
 Mean % (95% CI) | 53 (52.55–53.89) |
 Range | 0–92 |
Smoking, n = 1473 | |
 Active smoker | 237 (14.8%) |
 Non-smoker | 524 (32.8%) |
 Previous smoker | 712 (44.6%) |
EuroSCORE II, n = 1604 | |
 Mean ± SD (95% CI) | 1.45 ± 2.08 (1.35–1.55) |
 Range, score | 0.5–39.62 |
Diabetes mellitus, n = 1561 (%) | 204 (13.1%) |
Previous AMI, n = 1557 (%) | 119 (7.6%) |
Previous PCI, n = 1555 (%) | 110 (7.1%) |
Lipid-lowering treatment, n = 1538 (%) | 707 (46%) |
Hypertension treatment, n = 1528 (%) | 873 (57.1%) |
Previous Operations, n = 1602 (%) | |
 0 | 1476 (92.1%) |
 Previois aortic valve operation | 11 (0.7%) |
 Other heart surgery | 39 (2.4%) |
BSA, n = 1486 | |
 Mean ± SD, m2 (95% CI) | 1.89 ± 0.2 (1.88–1.90) |
 Range, m2 | 1.34–2.67 |